Scienze dell'Interazione anno 2012 n.1-2 - Scuola di ...

STUDI, RICERCHE E DIBATTITI Antonio Iudici
Marzocchi G.M., Oosterlaan J., De Meo T., Di Pietro M., Pezzica S., Cavolina P.,
Sergeant J., Zuddas A. (2001) Scala di valutaz. dei Comportamenti Dirompenti per
insegnanti (SCOD-I): validazione e standardizzazione di un questionario per la
valutazione dei comportamenti dirompenti a scuola. Giornale di Neuropsichiatria
Età Evolutiva, 21:378-93.
Masi G., Millepiedi S., Mucci M.(2002) ADHD.: diagnosi differenziale. AIDAI.
Max J., Arndt S., Castillo C., Bokura H., Robin D., Lindgren S., Smith W., Sato Y.,
Mattheis P. (1998) ADHD symptomatology after traum. brain injury: a prospect.
study. J of Am. Academy of Child and Adol. Psychiatry;37:841-7.
Maziade M. (1989) Should adverse temperam. matter to the clinician?An
empirically based answer. In: Kohnstamm GA, Bates JE, Rothbart MK, Temper. in
childhood. N.York: Wiley.
Mc Devitt S.C., Carey W.B. (1978) The measurement of temperament in 3-7 year
old children. J. of Child Psychology and Psychiatry;19:245-53.
Moll G.H., Hause S., Ruther E., Rothenberger A., Huether G., (2001) Early
methylphenidate administration to young rats causes a persistent reduction in the
density of striatal dopamine transporters. J. Child Adol. Psychopharm., Spring
11(1): 15-24.
Montiel Nava C., Pena J.A., Espina Marines G., Ferrer-Hernandez M.E., Lopez-
Rubio A., Puertas-Sanchez S., Cardozo-Duran J.J. (2002) A pilot study of
methylphenidate and parent training in the treatment of children with ADHD, Rev
Neurol. 1-15;35(3):201-5.
Nasrallah H. et al. (1986) Cortical atrophy in young adults with a history of
hyperactivity in childhood. Psychiatric Research; 17:241-246.
N.I.H.: Consensus Development Conference Statement (1988), Nov 16-18.
NIMH Psychophar. Resear. Branch (1976) Divis. of Extramural Research Progr.,
218-222.
NIMH (National Institute of Mental Health) (1985) CGI (Clinical Global Impress.
Scale), Psychopharm. Bull. 21:839-844.
Novartis Pharmaceuticals Corporation (2006) Ritalin La drug insert. NJ: Elan
Holdings, Inc..
Panei P.,Germinario E., Itro I., Marzi M., Bugarini M. ISS (2009) Protocollo
diagnostico e terapeutico della sindrome da iperattività e deficit di attenzione per il
Registro nazionale ADHD, III, 58 p. Rapporti ISTISAN 09/20.
Panei P., Knellwolf A.L, Arcieri R., Vella S. (2006) Absence of unfavorable effect of
atomoxetine on growth in pediatric patients is still not demonstrated.
Pediatrics,117:587-588.
Paneia P., Arcieria R., Bonatib M., Bugarinia M., Didonib A., Germinario A. (2010)
Sicurezza dei farmaci psicotr. prescritti in Italia per l’ADHD. Adverse Drug React.
Bull., 260.
Pauls D.L. (1991) Genetic factors in the expression of ADHD. Journal of Child and
Adolesc. Pharmacology, 1, 353-360.
Pelham W.E., Gangy E.M., Greenslade K.E,. Milich R.(1992) Teacher ratings of
DSM-III-R symptom for the disruptive behavior disorders.J Am Acad Child Adolesc
Psychiatr;31:210-8.
Pekkanen J., (2000) Making Sense of Ritalin, di Rider's Digest, 156(933).
Peterson, B.S. (1995) Neuroimaging in child and ado-lescent neuropsichiatric
disorders. J of American Academy of Child and Adolescent Psychiatry;34:1560-76.
Pillow D.R., Pelham W.E., Hoza B., Molina B.S., Stultz C.H. (1998) Confirmatory
factor analyses examining, attention deficit hyperactivity disorder symptoms and
other childhood disruptive behaviors. J Abnorm Child Psychol;26:293-309.
Plomin R., Owen M., McGuffin P. (1994) The genetic basis of complex human
behaviors. Science; 264:1733-9.
76